Indacterol derivatives and phosphodiesterase inhibitors for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4704 (2006.01) A61K 45/06 (2006.01) A61P 11/06 (2006.01)

Patent

CA 2609522

A medicament comprising separately or together, (A) a compound of formula (I) in free or salt or solvate form, where W, Rx, Ry, R1, R2, R3, R4, R5, R6 and R7 have the meanings as indicated in the specification, and (B) one or more of compounds selected from the group consisting of PDE4 inhibitors and PDE5 inhibitors, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.

L'invention concerne un médicament comprenant, séparément ou ensemble, (A) un composé de formule (I), se présentant sous une forme libre, ou sous une forme de sels ou de solvates, dans cette formule, W, Rx, Ry, R1, R2, R3, R4, R5, R6 et R7 présentent les significations indiquées dans la description, et (B) au moins un composé sélectionné dans le groupe comprenant des inhibiteurs de PDE4 et des inhibiteurs de PDE5, pour une administration simultanée, séquentielle ou séparée, dans un traitement de maladies inflammatoires ou obstructives des voies respiratoires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Indacterol derivatives and phosphodiesterase inhibitors for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indacterol derivatives and phosphodiesterase inhibitors for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indacterol derivatives and phosphodiesterase inhibitors for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2061769

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.